论文部分内容阅读
倍欣系新一代α-葡萄糖苷酶抑制剂，能选择性地抑制在消化、吸收最终阶段起作用的a一葡萄糖音酶，从而延缓肠道葡萄糖的吸收，对降低餐后血糖有明显的作用，尤其是使用磺腺类药物（SU剂）／胰岛素疗法仍然不能良好控制的2型糖尿病患者，与借欣合用后，可以降低餐后及空腹血糖。
Beixin is a new generation of α-glucosidase inhibitors, can selectively inhibit the final stage of digestion and absorption of a-glucose enzymes, which delay the intestinal absorption of glucose, reduce postprandial blood glucose have a significant role In particular, patients with type 2 diabetes who are still not well controlled using sulfonamide (SU agent) / insulin therapy can reduce postprandial and fasting blood glucose levels when combined with dexamethasone.